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Diastereomer.Abstract This study presents the first report of an ultrasound-assisted derivatization reac-
tion between a carboxylic acid of etodolac (ETO) and a chiral derivatization reagent,
(1R)-()-menthyl chloroformate (R-MCF). Fifty lL of deproteinated mouse serum containing
ETO enantiomers was derivatized with 125 lL of 200 mM R-MCF and 17 lL of pyridine (a cata-
lyst), with the reaction facilitated by ultrasonic radiation for 13 min, which were the optimal con-
ditions as determined by response surface methodology. After quenching the reaction by adding an
aqueous L-proline solution, the mixture was subjected to salting-out assisted liquid–liquid extrac-
tion (SA-LLE), which provided phase separation for sample concentration as well as cleanup.
The ETO diastereomers were separated on a Phenomenex Gemini C18 column (150  4.6 mm,
5 lm) under a simple gradient elution of a mobile phase containing a mixture of methanol: acetoni-
trile (10:1, V/V) and 10 mM acetic acid at a flow rate of 1.0 mL min1, followed by fluorescence
detection with excitation and fluorescence emission wavelengths of 235 nm and 345 nm, respec-
tively. The developed method was validated for specificity, sensitivity, linearity, accuracy, precision,
stability, and matrix effect. A good linearity in the range of 0.5–50.0 lg mL1 for each ETO enan-
tiomer with r2 > 0.998 and acceptable values for the intra-day and inter-day accuracy and precision; ETO,
proxen;
Ultrasound-assisted chiral derivatization of etodolac S1963as well as negligible matrix effects supported the suitability and reliability of the method. Finally,
this method was used to analyze real samples taken from mice treated with (±)-ETO.
 2015 The Authors. Production and hosting by Elsevier B.V. on behalf of King Saud University. This is
an open access article under theCCBY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
More than half of the drugs in current use contain one or more chiral
centers and are sold as either racemic mixtures or single enantiomers
(Brocks, 2006; Awad and El-Aneed, 2013). Enantiomers of chiral
drugs have identical physicochemical properties in achiral environ-
ments. However, they can have different pharmacodynamic, pharma-
cokinetic, and toxicological properties due to their different
stereospecific interactions with endogenous molecules in chiral envi-
ronments in vivo (McConathy and Owens, 2003; Smith, 2009; Shen
et al., 2013; Tougou et al., 2004; Lu, 2007). Because distinct enan-
tiomers should be considered as two separate drugs, they need to be
evaluated separately (Hewala et al., 2014). Accordingly, the develop-
ment of enantiomeric separation methods of racemic mixtures of drugs
is important for drug monitoring (Burke and Henderson, 2002; Miller
and Ullrich, 2008).
Many nonsteroidal anti-inflammatory drugs (NSAIDs) contain a
chiral center, but they are usually sold as a racemic mixture (Evans,
1992). For example, etodolac (ETO), [(RS)-2-(1,8-Diethyl-4,9-
dihydro-3H-pyrano[3,4-b]indol-1-yl) acetic acid], which was approved
by the FDA for treating rheumatoid arthritis and osteoarthritis (Boni
et al., 2000), has one chiral center. Although it is sold as a racemate,
only S-ETO is responsible for anti-inflammatory activity, while R-
ETO is useful in treating B-cell chronic lymphocytic leukemia and in
reducing the adverse effects associated with the administration of the
racemic mixture of ETO (Kolluri et al., 2005; Inoue et al., 2010;
Hardikar, 2008). After administration, ETO does not undergo in vivo
conversion between the S- and R-forms, and clearance of S-ETO is
approximately 13 times faster than that of R-ETO, resulting in an
effective 1:10 (S-) to (R-) physiological ratio in plasma (Hewala
et al., 2014; Boni et al., 2000). Therefore, quantitative enantiosepara-
tion of ETO in biological samples is necessary for accurate determina-
tion of the differential potencies in pharmacological and toxicological
aspects.
Similar to other enantiomers, chiral separation of ETO has been
achieved through the formation of either transient or formal diastere-
omers (Stalcup, 2010). Although there have been a few studies based
on capillary electrophoresis using chiral selectors (de Pablos et al.,
2005; Fanali et al., 2003), high performance liquid chromatography
(HPLC) analysis on a chiral stationary phase (CSP) using chiral col-
umns has been the main stream approach for enantiomeric separation
of ETO (Hewala et al., 2014; Becker-Scharfenkamp and Blaschke,
1993; Ali and Aboul-Enein, 2003; Ghanem et al., 2010; Caccamese,
1993), as chiral columns are convenient and do not raise the concern
of racemization during analysis. However, some chiral columns are
not commercially available (Boni et al., 2000) and are often of high
costs (Ghanem et al., 2010). Columns are usually available in
normal-phase mode, which requires the consumption of large volumes
of volatile organic solvents as mobile phase (Hewala et al., 2014;
Ghanem et al., 2010). These limit the practicality of CSP columns
for chiral separation.
Formation of formal diastereomers of ETO has been achieved by
chiral derivatization using a variety of chiral derivatization reagents
(CDRs) including S-(+)-amphetamine sulfate (Singh et al., 1986) for
gas chromatography, and (S)-1-(4-dimethylaminophenylcarbonyl)-3-a
minopyrrolidine (Ogawa et al., 2013), (S)-anabasine Higashi
et al., 2012, S-()-1-(1-naphthyl)-ethylamine (Jin et al., 2008),
(R)-(+)-a-methyl benzyl amine, (S)-()-a,4-dimethylbenzylamine, and
(R)-()-1-cyclohexylethylamine (Singh and Bhushan, 2015) for HPLC
analysis. These CDRs display some disadvantages, including thelengthy derivatization times required (Singh et al., 1986; Jin et al.,
2008), commercial unavailability (Ogawa et al., 2013), or high costs
(Higashi et al., 2012). Only a small number of studies were developed
for the ETO analysis in biological samples (Singh et al., 1986; Jin et al.,
2008), while several methods were not validated appropriately (Higashi
et al., 2012). Therefore, the development of indirect methods involving
CDRs that are more economical and readily available and that can pro-
duce stable products under mild conditions remains necessary.
In this study, we aimed to develop a new analytical method for the
simple and sensitive determination of ETO enantiomers in biological
fluids. To this end, (1R)-()-menthyl chloroformate (R-MCF) was
selected as the most appropriate CDR. R-MCF has been widely used
for enantiomeric separation of chiral drugs that contain amino or
hydroxyl groups by forming stable derivatives (Christensen et al.,
1995; Koo et al., 2012; Paik et al., 2006; Kino et al., 2004). This study
presents the first use of R-MCF as a CDR to react with a carboxylic
acid group of ETO. The derivatization reaction was facilitated effi-
ciently by ultrasound radiation and the reaction conditions including
the radiation time and the CDR volume were optimized by response
surface methodology (RSM). Fluorescence (FL) detection of the
ETO diastereomers, which was possible due to the native fluorescent
property of ETO (El Kousy, 1999), allowed for sensitive and selective
analysis by HPLC compared to ultraviolet detection. The validity of
the developed method was demonstrated by the reasonably acceptable
parameters of the method validation, and by its successful application
to real serum samples taken from mice that had been administered a
racemic mixture of ETO.
2. Materials and methods
2.1. Materials
(±)-ETO (>98.0%) was obtained from TCI (Tokyo, Japan).
R-MCF (>99.0%), pyridine, acetic acid, formic acid (FA),
L-proline, and S-naproxen sodium (S-NAP; >98%) were
purchased from Sigma–Aldrich (St. Louis, MO, USA).
Ethanol (EtOH) and sodium chloride (NaCl) were purchased
from Merck (Darmstadt, Germany). HPLC-grade water,
methanol (MeOH), and acetonitrile (ACN) were obtained
from J.T. Baker (Center Valley, PA, USA). A few lots of
mouse serum, each of which was a pooled preparation from
a normal mouse population and pooled for the method
development and validation processes, were purchased from
Sigma–Aldrich. Other chemicals were of analytical grade and
purchased from Sigma–Aldrich unless otherwise indicated.
2.2. Instruments and operation conditions
2.2.1. HPLC–FL analysis of ETO diastereomers for
quantitative assays
Quantitative chromatographic analyses were performed on an
Agilent Technologies 1260 Infinity Liquid Chromatographic
System (Agilent Technologies, Santa Clara, CA, USA)
equipped with a G1311C Quaternary Pump VL, a
G1316A Thermostatted Column Compartment, and a
G1321B fluorescence detector. For fluorescence detection, the
excitation and emission wavelengths were set at 235 and
S1964 Y. Jin et al.345 nm, respectively. The injection volume was 20 lL and the
chromatographic separation was performed on a Phenomenex
Gemini C18 column (150 mm  4.6 mm, 5 lm) at a flow rate of
1 mL min1 at 45 C. The mobile phase consisted of eluent A
(10 mM acetic acid) and eluent B (MeOH: ACN, 10:1 v/v). The
gradient elution was performed as follows: 0–10 min, 80–85%
B; 10–15 min, 85% B; 15–20 min, 85–90% B. After the gradi-
ent was returned to the initial conditions within 3 min, the col-
umn was re-equilibrated for 5 min before the next run.
HPLC–UV analysis, which was used to compare method
sensitivity of the HPLC–FL analysis, was performed using a
PerkinElmer LC system (Norwalk, CT, USA), equipped with
a PerkinElmer micro pump, a column oven (series 200), an
auto-sampler (series 275), and a photodiode array detector
(series 275). The system operation and data management were
conducted using TotalChrom Workstation software. Detec-
tion wavelength was set at 226 nm and the other chromato-
graphic conditions were the same as for the HPLC-FL
analysis.
2.2.2. UHPLC–QTOF–MS analysis of ETO diastereomers for
qualitative assays
Ultra-high performance liquid chromatography–quadrupole-
time-of-flight mass spectrometry (UHPLC–Q-TOF–MS) was
used for the qualitative analysis of ETO diastereomers. The
instruments employed were an Acquity UPLC system (Waters
Co., Milford, MA, USA) coupled to a Waters Acquity Xevo
G2 Q-TOF system (Waters Corp., Manchester, UK), which
had been used in our previous study (Nam et al., 2015). Over-
all, the operation conditions were similar to the previous study
with slight modifications. In brief, separation was achieved on
a ZORBAX Rapid Resolution High Definition Eclipse Plus
C18 column (100 mm  2.1 mm, 1.8 lm) from Agilent under
a simple gradient elution of the mobile phase consisting of
0.1% FA in water (A) and 0.1% FA in MeOH (B): 0–9 min,
80–90% B; 11–13 min, 100% B. Mass spectrometry was con-
ducted in positive ion mode and other MS parameter settings
were the same as those in Nam et al. (2015).
2.3. Preparation of standard and reagent solutions
A standard stock solution of racemic ETO was prepared at a
concentration of 1000.0 lg mL1 in ACN. Standard working
solutions were prepared in the range of 1.0–100.0 lg mL1
by subsequently diluting the stock solution in ACN. Stock
solution and working solution of S-NAP, the internal standard
(IS), were prepared in EtOH. All standard working and stock
solution were stored at 20 C until use. The derivatization
reagent, 200 mM R-MCF, was prepared in ACN and stored
at 4 C.
2.4. Chiral derivatization reaction procedure
Equal volumes of ETO working solution and mouse serum
were combined to yield 100 lL of a mixture which was then
spiked with 20 lL of a 1.0 lg mL1 solution of S-NAP. After
880 lL of ACN was added to precipitate protein, the mixture
was vortexed for 3 min and centrifuged at 12,300 g for 5 min.
A total of 950 lL of the supernatant was removed and dried
under nitrogen gas purge. The residues were derivatized as
follows: 125 lL of 200 mM R-MCF, 58 lL of ACN, and17 lL of pyridine were added, and the reaction mixture was
capped, followed by ultrasonic radiation for 13 min. The reac-
tion was quenched by the addition of 170 lL of 200 mM
L-proline solution and subsequently vortexed for 3 min
followed by incubation at room temperature for 10 min. Phase
separation was readily achieved by the addition of 20 mg of
NaCl to the reaction mixture and subsequent brief vortexing.
The upper organic phase of 140 lL was removed and filtered
through 0.45 lm pore membrane filters (Millipore, Tullagreen,
Ireland) before injection into the HPLC system.
2.5. RSM for the optimization of derivatization conditions
RSM based on a central composite design was performed
using Design-Expert 8 (Stat-Ease Inc., Minneapolis, MN,
USA). The optimized variables were as follows: (1) A, volume
of 200 mM R-MCF, (2) B, ultrasonic radiation time, and (3) C,
pyridine volume. The total sum of two peak areas of deriva-
tized ETO diastereomers was used as the response.
2.6. Assessment of the derivatization reaction rate
The derivatization reaction products of R- and S-ETO were
examined for 0–20 min of ultrasonic radiation. The reaction
conditions were based on the optimized conditions except for
the reaction time. The total peak areas of the R- and S-ETO
derivatives were used for the total reaction yields. Enan-
tiomeric fractions (EFs) were measured for the R-ETO deriva-
tives using the following equation (Polo-Diez et al., 2015;
Ribeiro et al., 2014):
Enantiomaric fraction ðEFÞ
¼ peak area of R enantiomer
peak area R enantiomerþ peak area of S enantiomer :2.7. Density functional theory method for computing dipole
moment of derivatives
A computational study using density functional theory (DFT)
was performed to compute dipole moment of the ETO deriva-
tives. The old, but popular B3LYP (Becke, 1993; Lee et al.,
1988) functional, and the more recent M06-2X (Zhao and
Truhlar, 2008) functional were considered. The basis set used
for all atoms was 6-31G(d) (Hehre et al., 1986). All computa-
tions were performed using Gaussian09 (Frisch et al., 2009).
The diastereomers, R-ETO:R-MCF and S-ETO:R-MCF were
fully optimized in MeOH and ACN as the solvents. Solvent
effects were taken into account in the framework of self-
consistent reaction field (SCRF) (Cances et al., 1997; Cossi
et al., 1996; Barone et al., 1998) based on Polarizable Contin-
uum Model (PCM) as developed by Tomasi’s group (Tomasi
and Persico, 1994). Frequency computations were performed
on the optimized diastereomers using the same methods as for
the optimization to check the nature of the stationary points.
2.8. Method validation
The established method was validated with respect to its
constituent parameters according to the United States Food
Ultrasound-assisted chiral derivatization of etodolac S1965and Drug Administration bioanalytical method validation
guideline (Food and Drug Administration, 2001).2.8.1. Specificity and sensitivity
Specificity was evaluated by comparing the chromatogram of
the blank serum sample with that of the serum sample spiked
with ETO and IS. Sensitivity was evaluated in terms of the
limit of quantitation (LOQ), which was determined based
on the determined analyte concentration at which the
signal-to-noise ratio was greater than 10.2.8.2. Linearity
Calibration curves for R- and S-ETO were established by spik-
ing racemic ETO into blank serum at 1.0, 2.0, 5.0, 10.0, 20.0,
50.0, and 100.0 lg mL1, which correspond to 0.5, 1.0, 2.5,
5.0, 10.0, 25.0, and 50.0 lg ml1 respectively, of each individ-
ual R- or S-ETO enantiomer.2.8.3. Precision and accuracy
Precision and accuracy were evaluated using quality control
(QC) samples that had been prepared by spiking ETO into
blank sera at three different concentrations (0.5, 5.0, and
50.0 lg mL1 for each enantiomer). The accuracy of the
method was expressed as the percentage of the observed con-
centration obtained from the calibration curves relative to
the predicted concentration. The precision was calculated as
the relative standard deviation (% RSD). Intra-day assay pre-
cision and accuracy were assessed by analyzing the QC sam-
ples in five replicates on the same day. Inter-day precision
and accuracy were evaluated by analyzing the QC samples in
three replicates on three successive days.2.8.4. Autosampler stability
The autosampler stability of the ETO derivatives in the pre-
pared samples was monitored at three concentrations (0.5,
5.0, and 50.0 lg mL1 for R- and S-ETO) at different time
intervals. Nine samples were prepared at once, three of which
were analyzed immediately (t= 0 h), while the remaining sam-
ples were stored at 4 C and analyzed after 24 h (n= 3) and
48 h (n= 3) of storage. The relative deviations from the initial
concentration after 24 and 48 h were calculated.2.8.5. Matrix effects
Matrix effects were assessed in the following two methods.
First, matrix-free standard solutions were prepared in ACN
at the same concentration levels as used for the calibration
curves prepared in serum matrices. The slopes of the external
standard curves were compared to those of the standard addi-
tion curves. In the second method, the signals of the QC sam-
ples prepared in serum and the matrix-free samples prepared in
ACN were compared at three concentrations level (n= 3).
Peak area ratios of R- and S-ETO to IS in ACN and serum
were measured, and the matrix effects were calculated using
the following equation (Sergi et al., 2013; Chow et al., 2011):
Matrix effect
¼ peak area ratio in serum peak area ratio in ACN
peak area ratio in ACN
:2.9. Animal test for real sample analysis
Eight-week-old male ICR mice were purchased from Koatech
Co., Ltd (Seoul, Korea). All animal care procedures were con-
ducted in accordance with the US National Institutes of
Health Guide for the Care and Use of Laboratory Animals.
The procedures were reviewed and approved by the
Institutional Animal Care and Use Committee of the School
of Pharmacy, Sungkyunkwan University (Approval No.
SKKUIACUC-20150034). A single dose of ETO racemates
at 20 mg kg1 was administered via intraperitoneal injection,
and serum was collected 30 and 60 min after administration.
3. Results and discussion
3.1. Derivatization of ETO using R-MCF, and characterization
of its reaction chemistry
Chloroformates can react with aliphatic alcohols, amines, and
carboxylic acids to form carbonates, carbamates, and esters,
respectively (Matzner et al., 1964; Lee et al., 2014). These facts
suggest that both the secondary amine and the carboxylic acid
group of ETO are the functional groups capable of reaction
with R-MCF (Matzner et al., 1964). Pyridine has been used
as a catalyst and scavenger of the hydrogen chloride formed
during the derivatization reaction of chloroformates with ami-
nes and carboxylic acids (Lee et al., 2014; Farsam et al., 1999).
Based on the above facts, we examined the derivatization
reactions between ETO racemates and R-MCF with and with-
out the addition of pyridine. The multiple conjugated structure
of ETO enables its detection by fluorescence emission (El
Kousy, 1999) and ultraviolet absorption (Helmy and
El-Bedaiwy, 2014). In this study, we used an FL detection sys-
tem to attempt to selectively and sensitively detect ETO and its
derivatives. For quantification, enantiomerically pure S-NAP,
which is an NSAID with a carboxylic acid moiety and that
possesses a native fluorescent property, was used as the IS.
First, derivatization was performed using 200 lL of 20 mM
R-MCF in the absence of pyridine. As a result, the intact ETO
peak was decreased, while no new peak was detected in the
chromatogram of HPLC–FL analysis (Supplementary
Fig. S1). On the other hand, UHPLC–Q-TOF–MS analysis
of the derivatization products displayed one new peak, which
had not been visible by the FL detection, in addition to the
native ETO peak, which decreased. The accurate masses of
the molecular ion and its fragment ions revealed that the
new peak corresponded to a carbamate derivative of ETO
formed between the indole amine of ETO and R-MCF (Table 1
and Supplementary Fig. S2). The ETO diastereomeric deriva-
tives could not be resolved using a typical reversed phase C18
column in the UHPLC system. It is likely that the menthyl
group attached directly on the indole amine induced fluores-
cence quenching in the ETO moiety. Thus, we concluded that
the R-MCF derivatization without pyridine was inapplicable
for producing ETO diastereomers suitable for enantiosepara-
tion using HPLC–FL.
In contrast, pyridine added to the derivatization reaction at
a volume of 30 lL yielded very different results. The native
ETO peak was decreased, and two incompletely resolved peaks
were found to elute later in the HPLC–FL chromatogram
under a simple gradient elution with an aqueous MeOH
Table 1 MS data for the R-MCF derivatives.
Analyte Elemental
composition
Exact mass Measured mass Mass error (ppm/mDA) Mass fragment
ETO carbamate derivativea C28H39NO5 492.2726 ([M+Na]
+) 492.2719 1.4/0.7 270.1486, 228.1379
ETO ester derivativeb C27H39NO3 426.3008 ([M+H]
+) 426.3007 0.2/0.1 288.1597, 172.1123
IS ester derivativec C24H32O3 391.2249 ([M+Na]
+) 391.2243 1.5/0.6 231.1017, 185.0960
a Peak 1 in Fig. 1.
b Peaks 2 and 3 in Fig. 1.
c Peak 4 in Supplementary Fig. S1.
S1966 Y. Jin et al.mixture (data not shown). Based on the UHPLC–Q-TOF–MS
analysis of the reaction products, it was confirmed that the two
peaks were ETO ester diastereomers that had been produced
by the reaction of R-MCF with the carboxylic acid group of
ETO (Table 1 and Supplementary Fig. S2). Fluorescence of
the derivatives produced in the presence of pyridine yielded
levels similar to that of the native ETO under the same detec-
tion conditions. Accordingly, we used the same excitation and
emission wavelengths for the derivatives as for native ETO,
with which the peak of S-NAP diastereomer also yielded a sig-
nal similar to that of the native S-NAP. The two derivatization
reactions, differing according to the presence of pyridine, are
shown in Fig. 1.Figure 1 Schemes for the derivatization reactions with R-MCF.
derivatization in the presence of pyridine, and (c) IS (S-NAP) derivat
center.3.2. Chromatographic resolution of the ETO diastereomers
Since diastereomers have very similar but not identical chemi-
cal and physical properties, they can be resolved on conven-
tional achiral columns. In our initial study, the two
diastereomeric derivative peaks were not completely resolved
and an interfering endogenous peak slightly overlapped with
the peak of the second diastereomer that eluted under the
aqueous MeOH solution gradient. Accordingly, we attempted
to optimize the chromatographic conditions to achieve
improved resolution of these overlapping peaks.
To this end, we investigated the effects of the properties of
aqueous and organic solvents in the mobile phase, and of(a) ETO derivatization in the absence of pyridine, (b) ETO
ization in the presence of pyridine. The asterisk indicates a chiral
Table 2 Electric dipole moment (Debye) of the two fully
optimized diastereomers using B3LYP/6-31G(d) and M06-2X/
6-31G(d) methods in MeOH and ACN.
Method R-ETO diastereomer S-ETO diastereomer
MeOH
B3LYP/6-31G(d) 6.97 6.67
M06-2X/6-31G(d) 7.16 6.63
ACN
B3LYP/6-31G(d) 6.99 6.68
M06-2X/6-31G(d) 7.17 6.64
Ultrasound-assisted chiral derivatization of etodolac S1967column temperature, while modifying gradient elution condi-
tions as appropriate. First, we found that changing the mobile
phase component from water to 10 mM acetic acid as eluent A
yielded a baseline separation of the two ETO diastereomers.
However, the problem of the second diastereomer peak over-
lapping with the following impurity peak still remained. Thus,
we changed the organic solvent of the mobile phase from
MeOH to ACN, which resulted in a distinct separation
between the second diastereomer and the interfering peaks,
although the two ETO diastereomers could not be separated
at baseline. We then combined MeOH and ACN at various
ratios, and found that a mixture of MeOH and ACN at 10:1
(v/v) yielded baseline separation of the two diastereomers
and impurity peaks (data not shown). All of these modifica-
tions were performed at a column temperature 25 C. Finally,
the effect of column temperature was examined, varying from
25 C to 45 C. It was found that the shortest run time without
compromising resolution was achieved at 45 C, which was
accordingly selected as the column temperature for the final
chromatographic conditions as described in Section 2.2.1.
The total chromatographic run time was 23 min.
3.3. Differentiation between R- and S-ETO diastereomers by
in vivo assay and computational study
Direct identification of the R- and S-ETO diastereomers was
not achievable because enantiomerically pure ETO standards
could not be obtained. Nonetheless, resolution of the R- and
S-ETO is still meaningful as previously reported (Higashi
et al., 2012; Singh and Bhushan, 2015). Differentiation
between the two diastereomers was inferred from in vivo assay
results. Serum samples taken from ICR mice 30 min and
60 min after administration of (±)-ETO were prepared using
the initial derivatization conditions involving pyridine, and
were promptly analyzed by HPLC–FL. Based on previous
stereoselective pharmacokinetic studies of ETO that showed
a predominant chiral disposition of the R-form in vivo due to
the rapid metabolism of the S-form (Boni et al., 2000;
Brocks and Jamali, 1990), we concluded that the first eluting
diastereomer peak (peak 2), which was always much larger
than the second peak (peak 3), was the R-ETO diastereomer,
followed by the second peak, corresponding to the S-ETO
diastereomer (Supplementary Fig. S3).
To complement our experimental investigations, we also
performed a computational study using DFT to compute
dipole moment, which is a useful parameter to understand
the order of elution in LC. The coordinates of the optimizedstructures of the two diastereomers, R-ETO:R-MCF and
S-ETO:R-MCF, are given in Supplementary Table S1. The
electric dipole moments of the two fully optimized diastere-
omers are summarized in Table 2. As per the experimental con-
ditions, the eluting solvents are relatively polar and the
stationary phase is non-polar in the reversed phase HPLC.
Therefore, as a general rule, a solute that is more polar is
expected to have a shorter elution time. The computed dipole
moments indicate that the R-ETO derivative is more polar
than the S-ETO derivative, and that the R-form is likely to
elute ahead of the S-form. These results are consistent with
those by in vivo assay. Therefore, it was concluded that the
peaks 2 and 3 corresponded to the R- and S-ETO diastere-
omer, respectively.3.4. Optimization of R-MCF derivatization conditions and the
assessment of the derivatization reaction rates
Biological fluids usually require sample cleanup steps due to
matrix complexity. In this study, protein precipitation method,
which is one of the most popularly used methods, was used
because it is simple and rapid. The two commonly used depro-
teination solvents, MeOH and ACN (Kole et al., 2011), both
of which are easy to remove and have good dissolution capa-
bility for ETO, were tested, with the vortexing time fixed at
three min to ensure complete mixing of serum and solvent. It
was found that ACN yielded significantly higher total peak
areas of the ETO derivatives than MeOH (p< 0.001) (Supple-
mentary Fig. S4). As a result, ACN was used as the protein
precipitation solvent in the subsequent experiments.
It was necessary to optimize the reaction conditions for R-
MCF and ETO because previously published conditions
employing R-MCF had only been established for reactions
with amines, not carboxylic acids. A literature search and
our own experiences with derivatization reactions involving
chloroformate (Matzner et al., 1964; Lee et al., 2014) suggested
that R-MCF derivatization could be affected by a number of
variables, including the ratio of R-MCF to ETO and pyridine
volume. Recently, alternative energy inputs such as microwave
and ultrasound-assisted mixing have been proven to improve
conventional organic synthesis (Baig and Varma, 2012). With
regard to this, our preliminary experiments indicated that
derivatization efficiency was significantly influenced by the
external factor of whether and how contact between R-MCF
and ETO was facilitated. Specifically, ultrasonic radiation of
the reaction mixture was more efficient than incubation with-
out agitation or vortexing for the same given period (data
not shown). Thus, ultrasound-assisted derivatization was
selected and the ultrasonic radiation time was included as a
variable to be optimized while the ultrasonic power was set
to maximum. In order to efficiently determine the optimal
reaction conditions and explore the interactions between these
variables, we applied RSM using a central composite design.
The following three variables were varied from the level of
1 to +1, and a sufficient volume of ACN was added to the
reaction mixture to bring the final volume to 200 lL: (1) vari-
able A, volume of 200 mM R-MCF (50–140 lL), (2) variable
B, ultrasonic radiation time (5–18 min), and (3) variable
C, pyridine volume (7–24 lL). The sum of the peak areas of
R- and S- ETO derivatives was used as the response. The
experimental design included 20 independent experiments
Figure 2 HPLC–FL chromatograms of samples prepared from
blank serum (a), serum spiked with IS (b), and serum spiked with
(±)-ETO and IS (c). The spiked concentrations for (±)-ETO and
IS were 50.0 and 1.0 lg mL1, respectively. Peak identification:
peaks 2, 3, and 4 correspond to compound 2 (ester derivative of R-
ETO), 3 (ester derivative of S-ETO), and 4 (ester derivative of IS)
in Fig. 1.
S1968 Y. Jin et al.including 6 center points, 8 factorial points, and 6 axial points,
and the experiments were performed in random order. As a
result, the response was fitted to a polynomial quadratic equa-
tion using the coded factors as follows:
Peak area ¼ þ1080:31þ 258:07 Aþ 188:75 Bþ 113:94
 C 116:37 ABþ 72:98 AC 42:3 BC
 106:79 A2  155:93 B2  159:01 C2
Based on the results of analysis of variance (ANOVA)
(Supplementary Table S2), the constructed model was highly
significant (p= 0.0003) with a satisfactory adjusted coefficient
(R2adj ¼ 0:8639). The regression model showed that all first-
order and second-order terms for the three variables had sig-
nificant coefficients. A negative interactive effect was observed
between the R-MCF volume and ultrasonic radiation time.
The results indicated that larger volumes of R-MCF and
pyridine, and longer ultrasonic radiation time, generally
contributed to higher peak areas of the diastereomers
(Supplementary Fig. S5).
Based on the constructed model, the optimized conditions
were determined to be 125 lL, 13 min, and 17 lL, for the
R-MCF volume, ultrasonic radiation time, and pyridine
volume, respectively. The derivatization reaction time of
13 min is much shorter than those by Jin et al. (2008) and
Singh and et al. (1986) and it is comparable to or slightly
longer than the reactions using (S)-anabasine (Higashi et al.,
2012), (R)-(+)-a-methylbenzylamine (Singh and Bhushan,
2015). The derivatization was reproduced under these opti-
mized conditions, and the resulting peak areas, 1180.6
(±90.7, n= 3), were found to be reasonably close to the pre-
dicted values (1244.8; 95% PI, 899.9–1589.6).
Under the optimized conditions, the reaction rates for R-
and S-ETO were examined in the time course of derivatization
reaction facilitated by ultrasonic radiation. As displayed in
Fig. 3a, the derivatization reaction yields increased sharply
for the beginning five min and continued to increase until
10 min, after which no significant changes were observed.
EFs for R-ETO also reached the maximum after 10 min of
reaction and remained unchanged thereafter (Fig. 3b). These
results indicate that the reaction rate of S-ETO is faster than
R-ETO in the beginning and that after 10 min of ultrasonic
radiation, the reaction rates of the two enantiomers reached
the steady state. At the optimal derivatization conditions of
which the derivatization reaction time was 13 min, it can be
inferred that the derivatization reaction rates were consistent.
Consequently, the subsequent method development was con-
ducted under these optimized conditions.
3.5. Salting-out assisted liquid–liquid extraction of the
derivatives
After derivatization, 170 lL of aqueous L-proline solution was
added to 200 lL of the reaction mixture to quench the reac-
tion. This step introduced an unintended dilution of the sample
and therefore decreased sensitivity. We adopted a salting-out
assisted liquid–liquid extraction (SA-LLE) strategy to improve
sensitivity (Farajzadeh et al., 2013; Wang et al., 2013). SA-
LLE is performed by adding an electrolyte to an aqueous mix-
ture to result in the phase separation between water-miscible
organic solvent and water. SA-LLE has been widely appliedto achieve increased analyte concentrations as well as sample
cleanup (Valente et al., 2013; Wen et al., 2013). Specifically,
we added NaCl to the quenched reaction mixture as a
salting-out agent. Of various amounts tested from 0 to
20 mg, 20 mg of NaCl was found to be sufficient to readily
induce phase separation of consistent volumes of the organic
phase (data not shown). The derivatized products were found
to be enriched in the resulting upper organic phase of more
than 140 lL. While the entire SA-LLE procedure could be per-
formed within less than 2 min, it helped achieve a relatively
high sensitivity for ETO analysis in biological fluids.
3.6. Method validation
3.6.1. Specificity, sensitivity, and linearity
Specificity of the developed method was confirmed in the chro-
matograms of samples prepared from blank and spiked sera.
No endogenous interfering peaks overlapped with the peaks
of the ETO and IS derivatives (Fig. 2). The LOQ values mea-
sured based on the signal-to-noise ratio were 0.3 lg mL1 for
both R- and S-ETO. The linearity of the calibration curves
that were established using spiked mouse sera was found to
be in the range of 0.5–50.0 lg mL1 for both enantiomers with
Figure 3 Total reaction yields of R- and S-ETO derivatives (a)
and the enantiomeric fractions of the R-ETO derivative (b) in the
time course of derivatization facilitated by ultrasound radiation.
Error bars indicate the SEM (n= 3).
Ultrasound-assisted chiral derivatization of etodolac S1969correlation coefficients (r2) above 0.998. The parameters of the
calibration curves are summarized in Table 3.
3.6.2. Precision and accuracy
The intra-day accuracy and precision for R-ETO were 96.2–
99.8% and 2.2–6.2%, respectively, while the inter-day
accuracy varied between 96.9% and 99.8% and the precision
ranged from 1.9% to 6.1% (Table 4). In the case of S-ETO,
the intra-day accuracy ranged between 97.0% and 108.7%
while the precision ranged from 2.3% to 7.7%. The inter-day
accuracy and precision for S-ETO were 97.9–107.8% and
2.2–7.8%, respectively. The quality of the intra- and inter-
assay precisions and accuracies indicated that our method
was suitable and reliable for analysis of the two enantiomers.
3.6.3. Stability
Stability of the R- and S-ETO derivatives was assessed using
the QC samples at three different concentrations. R- andTable 3 Linearity and LOQ of the developed method.
Analyte Calibration curve r2
R-ETO y= 0.1205x  0.02000 0.9987
S-ETO y= 0.1275x  0.02207 0.9991S-ETO were relatively stable in their derivative forms at 4 C
for at least 48 h (Supplementary Table. S3). These results show
that the R-MCF ester derivatives are relatively stable, and sug-
gest that the developed method may be applied for routine
analysis of a number of clinical samples that cannot be ana-
lyzed in a single day.
3.6.4. Matrix effects
Although the matrix effect is generally a critical aspect of
hyphenated MS techniques, it is also important to assess in
the quantification methods for samples of complex matrices
such as biological samples. In this study, the matrix effect
was evaluated in two ways. The slope ratios of the external
standard curves to the standard addition curves were deter-
mined to be 1.05 and 1.06 for R-ETO and S-ETO, respectively.
Given that the slopes of the curves did not diverge (<10% dif-
ference), it could be concluded that there was no matrix effect.
Matrix effects (%) obtained from the peak area ratios of R-
and S-ETO to IS in ACN and serum were 15.9%, 4.0%, and
5.5% at low, intermediate, and high concentrations, respec-
tively, for R-ETO; 11.9%, 6.4%, and 5.9% at low, intermedi-
ate, and high concentrations, respectively, for S-ETO. Both
results indicate that no significant matrix effects were evident.
3.7. Comparison of the developed method to other methods and
application of the developed method
ETO has been analyzed by HPLC–UV in chiral quantification
methods (Boni et al., 2000; Jin et al., 2008; Singh and Bhushan,
2015). In this study, we compared the two detection methods,
UV and FL with respect to sensitivity and selectivity. In the
chiral derivatization reaction, pyridine that was added as a cat-
alyst was unavoidably retained in the sample after SA-LLE.
Because pyridine has a strong UV absorbing property, its peak
overwhelmed the HPLC–UV chromatograms at 226 nm that
was the maximal absorption wavelength for the ETO diastere-
omers upon wavelength scanning. The LOQ values of the
HPLC–UV method were 5.0 lg mL1 for both R- and S-
ETO, which is 17-fold higher than those of our developed
method based on the FL detection. These results support that
HPLC–FL analysis provides selective and sensitive determina-
tion of ETO enantiomers.
As summarized in Supplementary Table S4, the LOQ value
of the current method (0.3 lg mL1) is comparable to or lower
than those of other quantification methods for biological flu-
ids, and this sensitivity was achieved using only 50 lL of
sample volume. Specifically, the method reported by Hewala
and et al. (2014) consumed 500 lL of plasma to obtain the
LOQ values of 0.19–0.20 lg mL1, while slightly higher LOQ
values than that of our method were achieved using a plasma
volume of 150–200 lL (Jin et al., 2008). Although our method
involves the derivatization procedure that may elongate the
analysis time compared to direct chiral separation methods,
its derivatization time is reasonably acceptable, and it is muchLinear range (lg mL1) LOQ (lg mL1)
0.5–50.0 0.3
0.5–50.0 0.3
Table 4 Intra- and inter-day assay accuracies and precisions.
Analyte Concentration (lg mL1) Intra-assay (n= 5) Inter-assay (n= 3  3)
Accuracy (%) Precision (RSD%) Accuracy (%) Precision (RSD%)
R-ETO 0.5 98.4 6.2 96.9 6.1
5.0 99.8 2.4 99.8 1.9
50.0 96.2 2.2 97.0 3.3
S-ETO 0.5 108.7 7.7 107.8 7.8
5.0 100.2 3.1 99.3 2.2
50.0 97.0 2.3 97.9 3.4
S1970 Y. Jin et al.shorter than that of the bioanalytical study reporting 2 h of
chiral derivatization (Jin et al., 2008). In addition, our study
applied the protein precipitation in combination with SA-
LLE for sample cleanup and enrichment, which is simpler
and more rapid than solid phase extraction (Hewala et al.,
2014) or LLE (Becker-Scharfenkamp and Blaschke, 1993; Jin
et al., 2008).
The developed method was applied to real serum samples
taken from ICR mice administered (±)-ETO at a dose of
20 mg kg1 by intraperitoneal injection (n= 3). The serum
concentrations 30 and 60 min after administration were deter-
mined to be 26.7 and 13.9, 27.8 and 19.4, and 30.1 and
15.7 lg mL1, respectively, for R- ETO; and 2.4 and 1.2, 2.2
and 3.2, and 3.3 and 1.6 lg mL1, respectively, for S-ETO.4. Conclusions
A simple and rapid sample preparation method involving the chiral
derivatization of ETO using R-MCF, with the reaction facilitated by
ultrasonic radiation and subsequent SA-LLE of the derivatives, was
established via optimization of important variables of the derivatiza-
tion reaction by RSM. This is the first report of enantioseparation
by ultrasound-assisted diastereomer formation between the carboxylic
acid group of enantiomers and R-MCF. The resulting stable ETO
diastereomers could be baseline separated on a conventional C18
HPLC column under the simple optimized elution conditions. The
SA-LLE, which enabled a very simple sample cleanup as well as con-
centration of the ETO derivatives, and the subsequent fluorescence
detection of the derivatives, made the method selective and sensitive
while consuming only 50 lL of serum. The validity of the developed
method was demonstrated by successful application in the real serum
sample analysis after ETO administration to several mice.Acknowledgments
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